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1. Introduction 
The populations of England, Wales, and Northern Ireland made more than 60 million trips abroad in 2015 [1]. 
More than 700,000 of these trips were made to countries endemic for yellow fever, a potentially deadly, 
tropical disease transmitted by mosquitoes. The disease is preventable by vaccination and this study was 
undertaken to elucidate the geographical accessibility of yellow fever vaccination centres. 
Yellow fever control has been on the international public health agenda since 1851 and has remained a disease 
under tight international surveillance and control measures ever since together with diseases such as cholera, 
and pneumonic plague [2]. Due to its reservoir in monkey and other non-human primate populations in the 
rain forests of Africa and South America (the forest cycle is maintained with tree-living mosquitoes as vectors), 
yellow fever may never be eradicated [3]. The main control measure for yellow fever is therefore vaccination in 
combination with vector control in high risk areas as well as measures available to countries at risk of 
importing or exporting the disease such as vaccination certificate requirements, border vaccination, and 
emergency quarantine restrictions to reduce the international spread of the disease [2,4,5].  
Occasionally, there are large outbreaks in urban areas (urban cycle), where the transmission depends on the 
Aedes aegypti mosquito, which has spread in cities across the tropics in recent decades. A yellow fever outbreak 
in Angola and Democratic of Republic of Congo (DRC) in 2015-2016 with more than 7,000 suspected cases (965 
confirmed cases and 137 confirmed deaths) was a stark reminder of the emerging threat of urban yellow fever 
outbreaks [6,7]. Increased international travel, urbanisation, and the fact that many tropical countries have 
large unvaccinated populations make the prospects of new urban yellow fever outbreaks a particular concern. 
At least 42 cases of international spread were recorded in connection with the Angola-DRC outbreak to 
countries with vector presence and largely unvaccinated populations including China and Kenya [8]. 
The National Travel Health Network and Centre (NaTHNaC) has overseen the registration, training, clinical 
standards, and audit of yellow fever vaccination centres in England, Wales, and Northern Ireland in compliance 
with the International Health Regulations for yellow fever since 2005 [9] and this is the first study to evaluate 
the geographical accessibility [10] of the yellow fever vaccination services. The aims of the study were thus to 
map and ascertain the geographical accessibility of yellow fever vaccination centres, match the number of trips 
to countries with yellow fever risk to the number of vaccinations given per region, identify any underserved 
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populations and evaluate any need to regulate service provision, and gather data to support contingency 
planning in the event of a vaccine shortage. 
2. Methods 
Administrative data on the postcode location of yellow fever vaccination centres were extracted from the 
Yellow Fever Vaccination Programme database (NaTHNaC, 27 October 2016). Occupational Health 
departments (N=218) were excluded as these by definition were not open to the general public. A total of 3,222 
centres were registered. General practitioner (GP) practices were the most frequent type of centre (N=2,381). 
Of the 3,222 centres, 3,208 or 99.6% could be geo-located to Census 2011 lower layer super output area (super 
output area for Northern Ireland; this is the nearest equivalent unit and it will be referred to as lower layer 
super output area hereinafter) and UK Region using the Office for National Statistics (ONS) Postcode Directory, 
August 2016 [11]. The latest mid-year population estimates (2015) were obtained at lower layer super output 
area level from ONS [12] and the Northern Ireland Statistics and Research Agency (NISRA) [13]. The analyses 
were conducted at lower layer super output area (N=35,643), which had a mean (SD) population of 1,676 
(379). The average geodetic distance (crow-fly distance) from each population unit was calculated to each 
centre location using the Stata module, GEODIST [14] to determine the distance to the nearest centre at lower 
layer super output area level. The centres were assigned to distance categories according to the following 
population percentiles: 75th, 90th, 95th, and 99th. Data on the average number of vaccinations per centre across 
regions were obtained from annual surveys of the centres in 2013-2015 (NaTHNaC, unpublished data). 
Boundary data for Census output areas,  UK Regions and countries were obtained from the UK Data Service/ 
Edinburgh University Data Library [15], which contains National Statistics data (© Crown copyright and 
database right, 2016), NRS data (© Crown copyright and database right, 2016, Source: NISRA Website, 
www.nisra.gov.uk; accessed 17 November 2016), and OS data (© Crown copyright and database right, 2016). 
Boundary data for the Isle of Man, Republic of Ireland, and Scotland were obtained from Natural Earth 
(www.naturalearthdata.com; accessed 17 November 2016) . Maps were created using Quantum GIS 2.12 [16]. 
Data on trips abroad by UK region of residence undertaken in 2015 were obtained from ONS Social Surveys 
(Crown copyright; December 2016). Data on trips abroad by countries where the traveller spent most time and 
UK Region of residence were obtained from Office for National Statistics [1]. Data on countries with risk of 
yellow fever transmission were obtained from the World Health Organization [17]. Data on the number of 
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registered yellow fever vaccination centres in other countries were obtained from ministries of health 
websites, literature, and personal communication with health professionals (see references at Table 4). The 
numbers of trips abroad (departures) by country in 2013 (N=100) were obtained from the World Bank data 
repository [18]. Data analyses were carried out in Stata 14 [19]. 
3. Results 
The population weighted mean distance to nearest centre varied from 0.6km in London to 7.1km in Northern 
Ireland. The national mean distance was 2.4km and the maximum distance 30.9km. Only 1% of the general 
population had more than 16.1km to their nearest centre (99th percentile) (Table 1, Figure 1, Figure 2). 
A total of 713,548 trips to countries with yellow fever transmission risk were made by residents in England, 
Wales, and Northern Ireland in 2015 (Table 2). Nigeria (20.7%), Brazil (14.8%), and Kenya (13.8%) alone 
accounted for half of all trips and the ten most commonly visited countries combined accounted for 84.3% of all 
trips (Table 2). 
The number of centres by UK Region varied from 51 in Northern Ireland to 858 in London. The number of 
centres per population varied from 2.8 per 100,000 population in Northern Ireland to 9.9 per 100,000 
population in London. Nationally, there were 5.4 centres per 100,000 population (Table 3).  
The size of the centres in terms of the yearly number of vaccines administered was calculated from data 
submitted in annual surveys in 2013-2015. The average number nationally was 40 vaccines per centre. The 
London average was the highest at 59 vaccines per centre followed by Northern Ireland (45), South East (40), 
North West (38), North East (38), East of England (34), South West (34), Yorkshire and The Humber (29), West 
Midlands (28), Wales (27) and East Midlands (25). 
There was a linear relationship between the estimated number of yellow fever vaccines administered and the 
number of trips to countries with yellow fever risk by UK Region, which indicate that there is balance between 
supply and demand at the regional level (Figure 3). 
The number of centres per 100,000 international trips abroad was 6.1 in England, Wales, and Northern Ireland, 
which was below that of United States (12.1) and above the rest of World Top20 countries in terms of trips 
abroad (Table 4). 
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Table 1   Distance to nearest yellow fever vaccination centre for the general population by UK Region (km). 
Region Min Median Mean p75 p99 Max 
North East 0.0 2.1 3.2 3.8 20.2 28.3 
North West 0.0 1.6 2.0 2.7 8.7 25.0 
Yorkshire & The Humber 0.0 1.7 2.4 3.3 10.6 26.4 
East Midlands 0.0 1.7 2.7 3.5 15.9 21.9 
West Midlands 0.0 1.5 2.1 2.5 11.5 17.3 
East of England 0.0 1.5 2.8 3.6 14.6 20.9 
London 0.0 0.5 0.6 0.8 2.2 4.0 
South East 0.0 1.2 1.9 2.4 9.6 18.7 
South West 0.0 1.5 2.7 3.7 14.3 23.7 
Northern Ireland 0.0 3.9 7.1 11.9 26.4 30.9 
Wales 0.0 3.2 4.9 7.5 22.0 29.3 
Total 0.0 1.3 2.4 2.9 16.1 30.9 
Note: The national 56th percentile was 1.6km. The headers, p75 and p99, denote the 75th and 99th percentile, respectively.  
 
Table 2   Top10 Trips abroad to countries with yellow fever risk made by residents in England, Wales, and Northern Ireland. Source: 
International Passenger Survey 2015.  
Destination Freq. Percent Cumulative Percent 
Nigeria 147,856 20.7 20.7 
Brazil 105,331 14.8 35.5 
Kenya 98,392 13.8 49.3 
Ghana 66,558 9.3 58.6 
Gambia 42,329 5.9 64.5 
Trinidad & Tobago 37,589 5.3 69.8 
Uganda 31,814 4.5 74.3 
Argentina 31,188 4.4 78.6 
Colombia 22,764 3.2 81.8 
Peru 17,785 2.5 84.3 
Other 111,942 15.7 100.0 
Total 713,548 100.0 - 
 
Table 3   Trips abroad by Region of residence in England, Wales, and Northern Ireland in 2015 compared to the number of yellow fever 
vaccination (YFV) centres. YF Trips: trips to countries with yellow fever risk. Trips data source: International Passenger Survey 2015. 
Region Trips 
Abroad 
YF Trips YFV 
Centres 
Mean 
Distance to 
YFV Centre 
(km) 
Centres 
per 
100,000 
Pop 
Trips per 
100,000 
Pop 
YF Trips 
per 
100,000 
Pop 
London 14,596,697 350,422 858 0.6 9.9 168,287 4,040 
South East 10,338,088 114,840 572 1.9 6.4 115,536 1,283 
West Midlands 4,806,320 51,938 239 2.1 4.2 83,574 903 
East of England 5,777,899 50,538 324 2.8 5.3 95,087 832 
North West 6,568,124 39,169 251 2.0 3.5 91,557 546 
South West 4,629,680 35,501 299 2.7 5.5 84,619 649 
East Midlands 3,774,532 25,869 211 2.7 4.5 80,703 553 
Yorkshire & The 
Humber 
4,752,930 23,817 208 2.4 3.9 88,171 442 
North East 1,844,388 16,185 85 3.2 3.2 70,273 617 
Wales 2,183,671 5,267 110 4.9 3.5 70,462 170 
Northern Ireland 803,150 0 51 7.1 2.8 43,376 - 
Total 60,075,479 713,546 3,208 2.4 5.4 100,567 1,194 
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Table 4   Yellow fever vaccination centres per international trips abroad by country. 
Rank Country Trips abroad 
(millions) 
Yellow fever 
vaccination centres 
(YFVC) 
YFVC per 100,000 
trips abroad 
1 China [20] 98.2 168 0.2 
2 Germany [21] 87.5 2,072 2.4 
3 Hong Kong SAR, China [22] 84.4 2 <0.1 
4 United States [23] 61.9 7,493 12.1 
5 Russian Federation [24] 54.1 44 0.1 
6 England, Wales, N. Ireland 53.0 3,208 6.1 
7 Poland* 52.6 . . 
8 Canada [25] 33.0 1,050 3.2 
9 Italy [26] 27.8 330 1.2 
10 France [27] 26.2 162 0.6 
11 Ukraine* 23.8 . . 
12 Saudi Arabia [28] 19.2 435 2.3 
13 Netherlands [29] 18.1 968 5.3 
14 Japan [30] 17.5 22 0.1 
15 India [31] 16.6 34 0.2 
16 Hungary [32] 16.0 30 0.2 
17 Sweden** 15.9 . . 
18 Mexico [33] 15.9 6 <0.1 
19 Korea, Rep. [34] 14.8 23 0.2 
20 Switzerland [35] 12.4 108 0.9 
*) No data were obtained from Poland and Ukraine. **) The vaccine is in principle available from any vaccination centre including family 
doctors, hospitals and private travel clinics in Sweden. 
 
4. Discussion 
This is the first study to look at the geographical accessibility of yellow fever vaccination centres in England, 
Wales, and Northern Ireland. For comparison, recent studies of geographical accessibility to GP practices and 
pharmacies found that 84.8% of the general population in England and Wales lived within 1.6km of a GP 
practice [36]; for pharmacies it was 89.2% [37]. In the present study, only 56% of the population lived within 
1.6km of a yellow fever vaccination centre. For comparison, the number of active GP practices in England and 
Wales in August 2016 was 11,456 [38] and the number of pharmacies, 13,104 [39], whereas only 3,157 yellow 
fever vaccination centres were registered in England and Wales in October 2016. Only 1% of the population 
lived more than 16.1km away from a yellow fever vaccination centre. So, while the geographical accessibility of 
yellow fever vaccination centres is poorer than for general medical services, it does not seem unreasonable 
taking into account that long-haul trips to countries with yellow fever risk are likely to be planned and are, 
typically, private undertakings [40].  
There was a linear relationship between the estimated number of yellow fever vaccines administered and the 
number of trips to countries with yellow fever risk by UK Region, which indicate that there is balance between 
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supply and demand and hence an even service availability at the regional level. No under-served regions were – 
in other words – identified. 
The number of centres per 100,000 international trips abroad was 6.1 in England, Wales, and Northern Ireland, 
which was below that of United States (12.1) and above the rest of World Top20 countries in terms of trips 
abroad (Table 4). The reasons for the large variation internationally are likely to be different travel 
patterns/demand and differences in healthcare system. 
The detailed data of the accessibility of yellow fever vaccination centres, will allow the regulator to make 
contingency plans for future vaccine shortages to ensure that vaccination services can be accessed across all 
regions. It will, as an example, be possible to run various scenarios to see the impact on regional accessibility if 
the number of active centres were to drop during a shortage.   
There are a few limitations with using the International Passenger Survey (IPS) data to estimate the regional 
demand of yellow fever vaccinations. First, the IPS does not record all trips on cruise ships (not at all if 
embarkation was in the UK) and the trip may simply be recorded as ‘cruising’ as a generic, multi-country 
destination. In 2015, UK residents undertook an estimated 1.78 million cruise trips (7.7% of global figures) 
[41]. More detailed UK data were not available to estimate the number of trips that would have required yellow 
fever vaccination either due to exposure risk or itinerary-based vaccination certificate requirements. Data on 
the cruise tourism industry as a whole in 2011, however, suggest that only a small fraction of cruise trips is 
likely to require yellow fever vaccination [42]. The Caribbean and the Mediterranean account for more than 
70% of bed-days. Within the Caribbean most itineraries cover the ports in the United States, Bahamas, Eastern 
and Western Caribbean and the South American ports are much less visited. Most cruises only take seven days 
and use hub ports such as Miami, Fort Lauderdale, or San Juan, Puerto Rico, in the northern half of the 
Caribbean. South America accounts for 5.4% of the global number of bed-days and the majority of visits are to 
certain coastal regions outside the yellow fever risk areas. Future studies of actual itineraries (including inland 
trips and excursions) may be able to more realistically highlight any discrepancies between risk and protection, 
e.g. in South America and Eastern Panama [43]. Second, the data for yellow fever risk are provided by WHO at 
the country-level, whereas in practice it will for countries only partly endemic depend on a risk assessment of 
the individual traveller including regions to be visited within a country (which may change during large 
outbreaks), duration, and planned activities. Examples of countries that are only partly endemic are Brazil, 
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Peru, and Kenya. Third, if a traveller plan to visit more than one country, the IPS record relate to the country 
where the traveller spend the most time. A travel itinerary where a yellow fever risk country is only a 
secondary destination would therefore not be counted. Fourth, the IPS only cover about 0.2% of all trips abroad 
[1] and rarely visited destinations may not be detected. 
5. Conclusion 
The geographical accessibility of yellow fever vaccination centres was good across all major population centres 
considering that that long-haul trips to countries with yellow fever risk are likely to be planned. Vaccines 
administered was found correlated with the number of trips to yellow fever countries at regional level in 
England, Wales, and Northern Ireland, which indicate an even service availability. A large variation was found 
between countries in the number of yellow fever vaccination centres per trips abroad. England, Wales, and 
Northern Ireland were together with United States and the Netherlands among the countries with the most 
yellow fever vaccination centres per trips abroad. The reasons for the large variation internationally are likely 
to be different travel patterns/demand and differences in healthcare system.  
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FIGURE LEGENDS 
Figure 1    Distance to nearest yellow fever vaccination centre for the general population by UK Region (km). 
Figure 2   Distance (km) to nearest yellow fever vaccination centre in England, Wales, and Northern Ireland (lower layer super output area 
level). 
Figure 3   Estimated number of yellow fever vaccinations and trips to countries with yellow fever risk by region of residence in England, 
Wales, and Northern Ireland. Labels: North East (NE), North West (NW), Yorkshire & The Humber (YH), East Midlands (EM), West Midlands 
(WM), East of England (EE), London (LO), South East (SE), South West (SW), Wales (WA), Northern Ireland (NI). 
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